Candao, Dhen .

HRN: 21-44-19  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/02/2024
MUPIROCIN 2%, 15G (TUBE)
10/02/2024
10/09/2024
TOPICAL
15 G
BID
Multiple Soft Tissue Injury, SP Closed Reduction Of Zygomatic Bone
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: